EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Effects of asfotase alfa in adults with pediatric-onset hypophosphatasia over 24 months of treatment

Lothar Seefried, Franca Genest, Anna Petryk, Marina Veith

Bone · 2023

DOI: 10.1016/j.bone.2023.116856 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Bone, 2023. Verfasst von Lothar Seefried und 3 weiteren Autor:innen. Beteiligte Einrichtung: Osteology Department, Julius-Maximilians-Universität Würzburg, Würzburg, Germany. Electronic address: l-seefried.klh@uni-wuerzburg.de. Hauptthemen laut MEDLINE: Alkaline Phosphatase, Hypophosphatasia. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Alexion Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Hypophosphatasia (HPP) is a rare, heritable metabolic disorder caused by deficient activity of tissue-nonspecific alkaline phosphatase (TNSALP). Asfotase alfa (AA) is a human recombinant TNSALP that promotes bone mineralization and is approved to treat eligible patients with HPP. METHODS: This prospective single-center observational study evaluated AA in adults with pediatric-onset HPP over 2 years of treatment (ClinicalTrials.govNCT03418389). Primary outcomes evaluated physical function; secondary outcomes assessed quality of life (QoL) and pain. RESULTS: The study included 17 females and 5 males (mean age: 48.7 years). Median distance walked in the 6-Minute Walk Test increased significantly from baseline to 12 months (P = 0.034) and results were sustained. Median Timed Up and Go test time significantly decreased from baseline at 12 (P = 0.003) and 24 months (P = 0.005), as did the median chair rise time test at 12 (P = 0.003) and 24 months (P < 0.002). The change from baseline in usual gait speed was significant at 12 (P = 0.003) and 24 months (P = 0.015). Mean dominant and nondominant hand grip strength improved at 24 months (P = 0.029 and P = 0.019, respectively). Median Short Form 36 Physical Component Summary scores significantly improved from baseline at 12 (P = 0.012) and 24 (P = 0.005) months, and median Lower Extremity Functional Scale scores improved from baseline at 12 (P = 0.001) and 24 (P = 0.002) months. No significant change was noted in pain level at these timepoints. While injection site reactions occurred in 86.4 % of the participants, there were no severe side effects or safety findings. CONCLUSIONS: Adults with pediatric-onset HPP treated with AA experienced marked improvement in functional and QoL outcomes that were observed as early as within 3 months of initial treatment and were sustained over 24 months.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alkaline PhosphataseHypophosphatasiaMaleChildFemaleHumansAdultMiddle AgedQuality of LifeHand StrengthPostural BalanceProspective StudiesTime and Motion StudiesRecombinant Fusion ProteinsPainEnzyme Replacement TherapyImmunoglobulin G

Stichwörter der Autor:innen

6-Minute Walk TestHypophosphatasiaQuality of lifeRare disease

Substanzen

Alkaline PhosphataseRecombinant Fusion Proteinsasfotase alfaImmunoglobulin G

Autor:innen und Institutionen

  • Osteology Department, Julius-Maximilians-Universität Würzburg, Würzburg, Germany. Electronic address: l-seefried.klh@uni-wuerzburg.de.
  • Osteology Department, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.
  • Department of Global Medical Affairs, Alexion, AstraZeneca Rare Disease, Boston, MA, USA.

Förderung

  • Alexion Pharmaceuticals

Zitieren

APA

Seefried, L., Genest, F., Petryk, A., & Veith, M. (2023). Effects of asfotase alfa in adults with pediatric-onset hypophosphatasia over 24 months of treatment. Bone. https://doi.org/10.1016/j.bone.2023.116856

Vancouver

Seefried L, Genest F, Petryk A, Veith M. Effects of asfotase alfa in adults with pediatric-onset hypophosphatasia over 24 months of treatment. Bone. 2023. doi:10.1016/j.bone.2023.116856

BibTeX
@article{Seefried2023,
  author = {Seefried, Lothar and Genest, Franca and Petryk, Anna and Veith, Marina},
  title = {Effects of asfotase alfa in adults with pediatric-onset hypophosphatasia over 24 months of treatment},
  journal = {Bone},
  year = {2023},
  doi = {10.1016/j.bone.2023.116856}
}
Kostenlos starten →